SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-006619
Filing Date
2019-07-31
Accepted
2019-07-31 07:52:01
Documents
63
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sbbp-20190630x10q.htm 10-Q 1747958
2 EX-31.1 sbbp-20190630ex311046694.htm EX-31.1 17808
3 EX-31.2 sbbp-20190630ex3121a1c58.htm EX-31.2 17764
4 EX-32.1 sbbp-20190630ex32133c1dc.htm EX-32.1 17619
  Complete submission text file 0001558370-19-006619.txt   5653115

Data Files

Seq Description Document Type Size
5 EX-101.INS sbbp-20190630.xml EX-101.INS 1088943
6 EX-101.SCH sbbp-20190630.xsd EX-101.SCH 39285
7 EX-101.CAL sbbp-20190630_cal.xml EX-101.CAL 48260
8 EX-101.DEF sbbp-20190630_def.xml EX-101.DEF 122963
9 EX-101.LAB sbbp-20190630_lab.xml EX-101.LAB 394169
10 EX-101.PRE sbbp-20190630_pre.xml EX-101.PRE 275735
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 10-Q | Act: 34 | File No.: 001-37569 | Film No.: 19987401
SIC: 2834 Pharmaceutical Preparations